anyone hearing?





































Anything to deflect actual mgmt performance. They want to blow another $20M this month without anyone noticing. Do you think they will ever make the money back that was spent developing this drug?

Happy Holidays!
 










































Buried in the Q&A on the next quarterly conference call, someone will likely casually mention that the target is Q1 or Q2, 2017. There will be no explanation. There will be no sense of urgency.

Is this a case of incompetence around timeframes or something more damaging that hasn't been disclosed yet? Q3 was the original target date, then early Q4, and now 2017 is approaching.